Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Psivant Therapeutics

Request full access

Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a computation-first approach to drug design

Watertown, United StatesFounded 2022Biotech & Life Sciences

About Psivant Therapeutics

PsiThera, formerly Psivant Therapeutics, is a Watertown, Massachusetts-based biotechnology company that designs oral small-molecule drugs for immune and inflammatory diseases, areas that have historically relied on injected biologics. Its proprietary QUAISAR platform combines physics-based molecular simulation, machine learning and experimental biophysics to model biologically relevant protein motion and find transient, druggable binding pockets that static structure-based methods miss. The company's pipeline targets clinically validated cytokine pathways in the TNF superfamily and beyond, led by an oral TNF-alpha inhibitor and an oral TL1A program, with IL-6 among its initial targets. PsiThera originated as a Roivant spinout and now operates as an independent company.

Source: Dealroom company data

At a glance

Status
Operational
Employees
37
Open positions
None listed
Dealroom signal
50.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Drug Development, AI Drug Discovery, Techbio, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2025 $48M $190M Roivant Sciences · Lightstone Ventures · Eurofarma · YK Bioventures ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Psivant Therapeutics website traffic

Latest recorded traffic for Psivant Therapeutics is 600 monthly website visits, down 80.6% over the last three months. Psivant Therapeutics's team grew 60.9% over the past year.

Latest monthly visits600 3-month web change-80.6% 1-year team growth+60.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Psivant Therapeutics in the Watertown ecosystem

Live from Dealroom

The Psivant Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Lightstone Ventures
  • Samsara BioCapital
  • Roivant Sciences
  • Eurofarma
  • YK Bioventures
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Psivant Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Psivant Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.